The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The federal Project Grant award of $500,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at Washington University to accelerate the diagnosis of inflammatory arthritis. The project aims to harness single-cell T cell-receptor sequencing to develop innovative diagnostic approaches. The research is being conducted at Washington University's Office of Sponsored Research Services Division over a 2-year performance period from...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,857,470 Cooperative Agreement to The Geneva Foundation to develop a multiplex testing platform that can simultaneously detect and identify Plasmodium species infections. This platform will serve as both a diagnostic tool and an epidemiological surveillance tool. The project performance period is from June 1, 2024 to May 31, 2028. Under a $268,312 sub-award, Meso Scale...
The Department of Defense's Defense Health Agency awarded a $155,500 Project Grant to The Washington University's Office of Sponsored Research Services Division to support a research project titled "ACTIVATION OF AN IMMUNE EVASION-TO-IMMUNE RECOGNITION SWITCH THROUGH THE INDUCTION OF IRF3 SIGNALING IN CRPCS". The grant, funded through the Military Medical Research and Development program (CFDA 12.420), will be executed over a 2-year period from May 1, 2024 to April 30, 2026. The...
The Department of the Army Medical Command awarded a $157,500 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 1, 2021 to May 31, 2022 to restore functional ARF tumor suppression in non-small cell lung carcinoma through the use of peptide mimics. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
The Department of Defense's Defense Health Agency awarded a $700,032 Project Grant to Duke University under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective August 1, 2025 through July 31, 2029, will fund research to investigate "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC." This research aims to transform healthcare for military service members, veterans, and the broader public by...
The U.S. Defense Health Agency awarded a $1,161,428 Project Grant to the University of California, Los Angeles (UCLA) under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 1, 2025, supports the development of a "Fully Automated, Multimodal, and Multiplexed Ferrobotic System for Point-of-Care Pathogenic and Serological Tick-Borne Disease Diagnosis." This advanced biomedical research project aims to transform healthcare for military...
The U.S. Defense Health Agency awarded a $777,659 Project Grant to the Children's Research Institute in Washington, D.C. under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to transform healthcare for military service members, veterans, and the public, with a focus on innovative research addressing critical health challenges. Specifically, the award will fund the "Use of ProResolution and Restorative Pharmacology...
This $240,897 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma at single-cell resolution. The award was made to Duke University's Office of Research Administration on August 1, 2025, with a period of performance through July 31, 2027. The Military Medical Research and Development program funds advanced biomedical...